Novartis has agreed to buy New Jersey-headquartered The Medicines Company (MedCo) for US$ 9.7 billion. The buyout will give Novart...
Read More
An analysis undertaken by BioPharma Dive has identified 31 troubled biopharma companies that are at highest risk of going bankrupt...
Read More
Viatris, it is. More than three months after Mylan said it would combine with Upjohn, a division of Pfizer, the two companies have...
Read More
The trade war between the US and China and the changed focus of the latter on its pharma sector, has opened up a big opportunity f...
Read More
India’s Increased Dependence on Chinese APIs Causing Concern
India’s dependence on China importing active pharmaceutical ingr...
Read More
MUMBAI: It’s not just import of raw materials (active pharmaceutical ingredients, or APIs) from China that is giving sleepless n...
Read More
The Cadila Healthcare stock has corrected over 6 per cent in two days, following the warning Letter from the USFDA for its Moraiya...
Read More
Home-grown drug firms have 80 per cent of the Rs 1.36 trillion domestic pharmaceuticals market but when it comes to the top sellin...
Read More